secwatch.observer — SEC 8-K summary
======================================

Issuer:     GOLDENWELL BIOTECH, INC. (GWLL)
CIK:        0001800373
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001477932-25-000424
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Goldenwell Biotech dismisses auditor Michael Gillespie & Associates, engages KCCW
--------------------------------------------------------------------------------

- Dismissed Michael Gillespie & Associates on Jan 23, 2025; engagement lasted from Nov 14, 2024.
- No disagreements on accounting principles, disclosure, or audit scope during the period.
- Board approved dismissal and appointment of KCCW Accountancy Corp. as new independent auditor.
- KCCW did not consult with company on accounting issues prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800373/000147793225000424/0001477932-25-000424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800373/000147793225000424/gdwl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-000424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer